Optimizing blood pressure control in patients with nondiabetic glomerular disease
Related Experiment Video
Updated: May 2, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Kausik Umanath1, Julia B Lewis1, Jamie P Dwyer1
1Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI; Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN; and Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN.
Insights
Optimal blood pressure management is crucial for patients with glomerular disease and chronic kidney disease (CKD). A target below 140/90 mmHg is recommended, with lower goals for those with heavy proteinuria, using renin-angiotensin system inhibitors.
Area of Science:
- Nephrology
- Cardiovascular Medicine
Background:
- Hypertension is prevalent in patients diagnosed with glomerular disease and chronic kidney disease (CKD).
- Establishing optimal blood pressure targets for this patient population remains a significant clinical challenge.
Purpose of the Study:
- To review current data and provide evidence-based recommendations for blood pressure targets in patients with glomerular disease and CKD.
- To outline therapeutic strategies for managing hypertension in these individuals.
Main Methods:
- Systematic review of available clinical data and guidelines.
- Analysis of studies investigating blood pressure targets and proteinuria levels.
- Evaluation of the role of renin-angiotensin system inhibitors in treatment.
Main Results:
- A blood pressure target of less than 140/90 mmHg is supported by current evidence.
- Patients with significant proteinuria may benefit from a lower target of less than 130/80 mmHg.
- Renin-angiotensin system inhibitors are identified as a primary therapeutic agent.
Conclusions:
- Blood pressure management in glomerular disease and CKD requires careful consideration of proteinuria.
- Targeted antihypertensive therapy, particularly with renin-angiotensin system inhibitors, is essential for patient outcomes.
Abstract:
Hypertension is a common problem among patients with glomerular disease and CKD. Optimal blood pressure targets for these patients have been the source of much debate. Careful review of the available data supports a blood pressure target of less than 140/90 mmHg. Consideration for a lower goal of less than 130/80 mmHg should be given for patients with heavy proteinuria. Renin-angiotensin system inhibitors should be used as the cornerstone of therapy for all patients with glomerular disease and CKD.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Diabetic Nephropathy
Antihypertensive Drugs: Action of Diuretics
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome III : Nursing Management
